Literature DB >> 8194163

Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.

E Smeland1, R M Bremnes, A Andersen, R Jaeger, T J Eide, N E Huseby, J Aarbakke.   

Abstract

To examine directly the hepatic and renal toxicity of 7-hydroxymethotrexate (7-OH-MTX) without interference of the parent compound methotrexate (MTX), we purified and gave 100 mg/kg 7-OH-MTX to rats, a dose resulting in serum levels of 7-OH-MTX comparable with those achieved in the clinic after the administration of high-dose MTX (HD-MTX). After only 5 h, the 7-OH-MTX-treated rats demonstrated 2.6-fold increases in serum creatinine values and 2-fold elevations in serum aspartate aminotransferase (ASAT) levels as compared with the controls. Morphologic evidence of toxicity, however, was apparent only in the kidneys. Intraluminal cellular debris containing membranous material and deteriorated organelles was seen, but no precipitate of the delivered drug. The peak serum concentration of 7-OH was up to 939 microM, and concentrations of 7-OH-MTX declined triphasically, showing a t1/2 alpha value of 2.45 min, a t1/2 beta value of 30.5 min, and a terminal half-life (t1/2 gamma) of 240 min. The total clearance value was 14.5 ml min-1 kg, and the postdistributional volume of distribution (V beta) was 5070 ml/kg. Our results may indicate a direct toxic effect of 7-OH-MTX on kidney and liver cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194163     DOI: 10.1007/bf00685928

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  35 in total

1.  Recommended methods for the determination of four enzymes in blood.

Authors: 
Journal:  Scand J Clin Lab Invest       Date:  1974-06       Impact factor: 1.713

2.  Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.

Authors:  D D Von Hoff; J S Penta; L J Helman; M Slavik
Journal:  Cancer Treat Rep       Date:  1977-07

Review 3.  Clinical pharmacokinetics of methotrexate in children.

Authors:  Y M Wang; T Fujimoto
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 4.  High-dose methotrexate: a critical reappraisal.

Authors:  S P Ackland; R L Schilsky
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

5.  The effect of high-dose methotrexate on renal tubules as indicated by urinary lysozyme concentration.

Authors:  M Freeman-Narrod; J S Kim; H Ohanissian; K Mills; J W Smiley; I Djerassi
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

6.  Acute hepatotoxicity after high-dose methotrexate administration to rats.

Authors:  R M Bremnes; E Smeland; N E Huseby; T J Eide; J Aarbakke
Journal:  Pharmacol Toxicol       Date:  1991-08

7.  Sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of methotrexate and its metabolites in plasma, saliva and urine.

Authors:  M L Chen; W L Chiou
Journal:  J Chromatogr       Date:  1981-11-13

8.  Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemia.

Authors:  J D Borsi; E Sagen; I Romslo; P J Moe
Journal:  Med Pediatr Oncol       Date:  1990

9.  7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

Authors:  S A Jacobs; R G Stoller; B A Chabner; D G Johns
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

10.  The effects of diltiazem on methotrexate-induced nephrotoxicity.

Authors:  G Deray; D Khayat; P Cacoub; R Bourbouze; L Musset; A Baumelou; C Jacquillat; C Jacobs
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

View more
  5 in total

1.  The protective effects of Prunus armeniaca L (apricot) against methotrexate-induced oxidative damage and apoptosis in rat kidney.

Authors:  Nigar Vardi; Hakan Parlakpinar; Burhan Ates; Asli Cetin; Ali Otlu
Journal:  J Physiol Biochem       Date:  2012-11-10       Impact factor: 4.158

2.  Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial.

Authors:  Jeffrey A Sparks; Kathleen M M Vanni; Matthew A Sparks; Chang Xu; Leah M Santacroce; Robert J Glynn; Paul M Ridker; Daniel H Solomon
Journal:  J Am Soc Nephrol       Date:  2021-09-22       Impact factor: 10.121

3.  Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.

Authors:  Rhiannon N Hardwick; John D Clarke; April D Lake; Mark J Canet; Tarun Anumol; Stephanie M Street; Matthew D Merrell; Michael J Goedken; Shane A Snyder; Nathan J Cherrington
Journal:  Toxicol Sci       Date:  2014-07-31       Impact factor: 4.849

4.  High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.

Authors:  E Smeland; O M Fuskevåg; K Nymann; J S Svendesn; R Olsen; S Lindal; R M Bremnes; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

5.  Nimesulide increases the aldehyde oxidase activity of humans and rats.

Authors:  Lei Zhou; Xiao-Yan Pang; Xiang-Yu Hou; Lu Liu; Zi-Tao Guo; Xiao-Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2020-01-08       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.